Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's disease.
Finkelstein DI, Billings JL, Adlard PA, Ayton S, Sedjahtera A, Masters CL, Wilkins S, Shackleford DM, Charman SA, Bal W, Zawisza IA, Kurowska E, Gundlach AL, Ma S, Bush AI, Hare DJ, Doble PA, Crawford S, Gautier ECL, Parsons J, Huggins P, Barnham KJ, Cherny RA.
Finkelstein DI, et al. Among authors: doble pa.
Acta Neuropathol Commun. 2021 Sep 29;9(1):161. doi: 10.1186/s40478-021-01258-8.
Acta Neuropathol Commun. 2021.
PMID: 34588001
Free PMC article.
No abstract available.